Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Significant Drop in Short Interest

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) saw a significant decrease in short interest in September. As of September 30th, there was short interest totalling 39,900 shares, a decrease of 59.2% from the September 15th total of 97,700 shares. Currently, 0.2% of the shares of the company are sold short. Based on an average trading volume of 2,170,000 shares, the short-interest ratio is currently 0.0 days.

Bluejay Diagnostics Stock Performance

Shares of NASDAQ:BJDX remained flat at $0.12 during mid-day trading on Friday. 2,064,405 shares of the company were exchanged, compared to its average volume of 819,269. Bluejay Diagnostics has a 52 week low of $0.11 and a 52 week high of $38.96. The company has a 50 day simple moving average of $0.20 and a 200-day simple moving average of $2.24. The stock has a market capitalization of $38,908.80, a price-to-earnings ratio of 0.00 and a beta of 0.70.

Bluejay Diagnostics (NASDAQ:BJDX) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($5.12) EPS for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Bluejay Diagnostics stock. CVI Holdings LLC acquired a new position in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 66,165 shares of the company’s stock, valued at approximately $46,000. CVI Holdings LLC owned about 19.69% of Bluejay Diagnostics at the end of the most recent quarter. 18.47% of the stock is currently owned by hedge funds and other institutional investors.

About Bluejay Diagnostics

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.